project id: TCGA-SKCM; case submitter id: TCGA-BF-AAP8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.81; rna integrity number: 7.3; age at index: 58; days to birth: -21414; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 21414; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 447.0; icd 10 code: C44.601; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin of upper limb and shoulder; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 181; initial weight: 260.0; sample id: dbe59d5d-84db-4a73-9950-c48caea079fc; sample submitter id: TCGA-BF-AAP8-01A; portion id: 34af5054-b2df-45df-83bf-6465b310d253; portion submitter id: TCGA-BF-AAP8-01A-11; slide id: 8199291b-9706-4b9e-8284-5cde11b116e5; slide submitter id: TCGA-BF-AAP8-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; section location: TOP;